Cargando…
Impact of currently prescribed lipid-lowering drugs on plasma PCSK9 concentration: single or in combination study in rats
BACKGROUND: An emerging data suggested a significant impact of statins on PCSK9 concentration, while the rapid impacts of other lipid-lowering drugs such as ezetimibe and xuezhikang alone or in combination on PCSK9 and lipid profile have not been assessed. This study aims to investigate whether an e...
Autores principales: | Zhang, Yan, Liu, Jun, Li, Sha, Xu, Rui-Xia, Sun, Jing, Li, Jian-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931276/ https://www.ncbi.nlm.nih.gov/pubmed/24533584 http://dx.doi.org/10.1186/1476-511X-13-35 |
Ejemplares similares
-
Lipid Lowering Therapy and Circulating PCSK9 Concentration
por: Nozue, Tsuyoshi
Publicado: (2017) -
Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy
por: Cao, Ye-Xuan, et al.
Publicado: (2019) -
Impacts of ezetimibe on PCSK9 in rats: study on the expression in different organs and the potential mechanisms
por: Xu, Rui-Xia, et al.
Publicado: (2015) -
Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease
por: Xu, Rui-Xia, et al.
Publicado: (2014) -
Effects of currently prescribed LDL-C-lowering drugs on PCSK9 and implications for the next generation of LDL-C-lowering agents
por: Konrad, Robert J, et al.
Publicado: (2011)